2seventy bio Inc [NASDAQ: TSVT] jumped around 2.15 points on Tuesday, while shares priced at $4.95 at the close of the session, up 76.79%.
Compared to the average trading volume of 334.97K shares, TSVT reached a trading volume of 31465670 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about 2seventy bio Inc [TSVT]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for TSVT shares is $4.33 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on TSVT stock is a recommendation set at 3.50. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Goldman have made an estimate for 2seventy bio Inc shares, keeping their opinion on the stock as Sell, with their previous recommendation back on June 06, 2024. While these analysts kept the previous recommendation, Leerink Partners dropped their target price from $5 to $18. The new note on the price target was released on January 31, 2024, representing the official price target for 2seventy bio Inc stock.
The Average True Range (ATR) for 2seventy bio Inc is set at 0.35, with the Price to Sales ratio for TSVT stock in the period of the last 12 months amounting to 5.60. The Price to Book ratio for the last quarter was 1.12, with the Price to Cash per share for the same quarter was set at 3.73.
How has TSVT stock performed recently?
2seventy bio Inc [TSVT] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 90.38. With this latest performance, TSVT shares gained by 115.22% in over the last four-week period, additionally plugging by 12.50% over the last 6 months – not to mention a drop of -7.99% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for TSVT stock in for the last two-week period is set at 81.87, with the RSI for the last a single of trading hit 87.19, and the three-weeks RSI is set at 76.34 for 2seventy bio Inc [TSVT]. The present Moving Average for the last 50 days of trading for this stock 2.66, while it was recorded at 3.21 for the last single week of trading, and 3.89 for the last 200 days.
2seventy bio Inc [TSVT]: Deeper insight into the fundamentals
2seventy bio Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 4.95 and a Current Ratio set at 4.95.
Earnings analysis for 2seventy bio Inc [TSVT]
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for TSVT. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for 2seventy bio Inc go to 67.80%.
Insider trade positions for 2seventy bio Inc [TSVT]
The top three institutional holders of TSVT stocks are: KYNAM CAPITAL MANAGEMENT, LP with ownership of 5.95 million shares, which is approximately 11.4089%. GOLDMAN SACHS GROUP INC, holding 4.14 million shares of the stock with an approximate value of $$15.93 million in TSVT stocks shares; and GOLDMAN SACHS GROUP INC, currently with $$14.09 million in TSVT stock with ownership which is approximately 7.0308%.
